Unlikely association of multidrug-resistance protein 2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events.
Ray
Adrian S
AS
Cihlar
Tomas
T
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D015986:Confounding Factors, Epidemiologic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D026901:Membrane Transport Proteins / Q000235:genetics*; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*; D063065:Organophosphonates / Q000009:adverse effects*; D017354:Point Mutation; D020641:Polymorphism, Single Nucleotide; D051437:Renal Insufficiency / Q000139:chemically induced* / Q000235:genetics*; D000068698:Tenofovir
D000225:Adenine; D019380:Anti-HIV Agents; D026901:Membrane Transport Proteins; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D063065:Organophosphonates; D000068698:Tenofovir